Fresenius Kabi USA, LLC recall: Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL... and 3 related products
Stage 3 of 4: Ongoing
Last action
28 Jul 2026 Class II recall, Fresenius Kabi USA, LLC: Presence of Particulate Matter: Hair was found in products (4 lots or presentations)
api.fda.govLast synced 6 Aug 2026, 15:58 EDT
Tracker alerts
When the stage changes
[Promise copy: the email sent when this tracker's stage changes, and how to stop it. Written by the editor.]
Free. One click to unsubscribe, in every email. We do not sell or share addresses: privacy.